The long-term effects of sustained glucagon receptor activation in humans are the least understood piece of the Retatrutide safety profile
People who stop taking weight-loss medications for the treatment of obesity gain the weight back within an average of 1.7 years, and this rebound is accompanied by a worsening of cardiometabolic risk factors, such as glycated hemoglobin (HbA1c), systolic blood pressure, and cholesterol levels, according to a new review and meta-analysis
It supports blood sugar control , including stimulating insulin secretion and lowering glucagon in a glucose-dependent way
Consider scheduling an appointment at Temecula Body Contouring to speak with one of our experts and put your mind at ease
However, if youre already on an antidepressant for treatment, then you should avoid this supplement, as it could lead to a dangerous, potentially fatal condition known as serotonin syndrome